Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1616113-45-1

VRT-1353385 is a novel small molecule chemical compound with potential antimicrobial properties. It has demonstrated promising activity against a broad spectrum of pathogenic bacteria, including antibiotic-resistant strains such as MRSA and vancomycin-resistant Enterococci. VRT-1353385 inhibits bacterial growth by disrupting cell wall synthesis, positioning it as a potential candidate for the development of new antibiotics. Preliminary studies have also suggested that VRT-1353385 may exhibit low cytotoxicity, which could offer a safer alternative to existing antibiotic treatments. Further research and clinical trials are necessary to fully explore the potential of VRT-1353385 as an antibiotic agent.

1616113-45-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1616113-45-1 Structure

  • Basic information

    1. Product Name: VRT-1353385
    2. Synonyms: VRT-1353385;Antibiotic-202;8,8'-(1'-Acetylspiro[9H-fluorene-9,4'-piperidine]-2,7-diyl)bis[2,6-anhydro-7,8-dideoxy-D-glycero-D-manno-oct-7-ynitol];1-[2,7-bis[2-[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]ethynyl]spiro[fluorene-9,4'-piperidine]-1'-yl]ethanone
    3. CAS NO:1616113-45-1
    4. Molecular Formula: C35H39NO11
    5. Molecular Weight: 649.68426
    6. EINECS: 604-604-1
    7. Product Categories: N/A
    8. Mol File: 1616113-45-1.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: VRT-1353385(CAS DataBase Reference)
    10. NIST Chemistry Reference: VRT-1353385(1616113-45-1)
    11. EPA Substance Registry System: VRT-1353385(1616113-45-1)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1616113-45-1(Hazardous Substances Data)

1616113-45-1 Usage

Uses

Used in Pharmaceutical Industry:
VRT-1353385 is used as a potential antibiotic agent for its ability to combat a wide range of pathogenic bacteria, including antibiotic-resistant strains. Its mechanism of action involves disrupting cell wall synthesis, which could provide a new approach to treating bacterial infections.
Used in Antimicrobial Research:
In the field of antimicrobial research, VRT-1353385 is utilized for its potential to develop new antibiotics that can overcome the challenges posed by antibiotic resistance. Its low cytotoxicity profile makes it a promising candidate for further investigation and development.
Used in Clinical Trials:
As part of clinical trials, VRT-1353385 is used to evaluate its safety, efficacy, and potential side effects in treating bacterial infections. These trials are crucial for determining the compound's suitability as a new antibiotic treatment option.
Used in Drug Development:
In drug development, VRT-1353385 serves as a key component in the creation of new antimicrobial drugs. Its unique properties and potential to target antibiotic-resistant bacteria make it a valuable asset in the ongoing fight against bacterial infections.

Check Digit Verification of cas no

The CAS Registry Mumber 1616113-45-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,1,6,1,1 and 3 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1616113-45:
(9*1)+(8*6)+(7*1)+(6*6)+(5*1)+(4*1)+(3*3)+(2*4)+(1*5)=131
131 % 10 = 1
So 1616113-45-1 is a valid CAS Registry Number.

1616113-45-1Downstream Products

1616113-45-1Relevant articles and documents

PROCESS FOR PREPARING MANNOSE DERIVATIVES

-

Page/Page column 28-29, (2020/02/16)

The invention relates to a process to prepare a compound of the following formula (I): (I), in which P represents a protective group of a hydroxyl function which is a -COR1 group with R1 representing an aryl or a (C1C

MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS

-

Page/Page column 206-207, (2014/07/08)

The present invention relates to compounds useful for the treatment or prevention of bacteria infections. These compounds have formula (I). The invention also provides pharmaceutically acceptable compositions containing the compounds and methods of using the compositions in the treatment of bacteria infections. Finally, the invention provides processes for making compounds of the invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1616113-45-1